Australian researchers present potential new treatment option for nicotine addiction
July 08, 2024 by monash.edu
Australian researchers present potential new treatment option for nicotine addiction
Smokers seeking to conquer their addiction may have a new treatment option following the results from a clinical trial led by Monash University, which found a combination of varenicline and nicotine lozenges significantly improved smoking abstinence when compared with varenicline alone. Both varenicline and nicotine lozenges (a form of nicotine replacement therapy) are medications commonly used for smoking cessation. Varenicline is the most effective single therapy currently available for smoking cessation.
13.00% of the adult population are current smokers. There are approximately 2.6 million current smokers in Australia 15.20% of men are current smokers but only 10.90% of women.
SOURCE: GSTHR
